Last reviewed · How we verify

NCT06024460

Non-pharmacological Treatment vs Pharmacological Treatment for Non-acute Lumbar Disc Herniation

Recruiting now NA Last updated 11 September 2025
What this trial tests

NA trial testing non-pharmacological treatment strategy in Lumbar Disc Herniation in 200 participants. Currently enrolling.

Timeline
9 August 2023
Primary endpoint
31 December 2030
31 December 2030

Quick facts

Lead sponsorJaseng Medical Foundation
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment200
Start date9 August 2023
Primary completion31 December 2030
Estimated completion31 December 2030
Sites4 locations across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Jaseng Medical Foundation

Who can join

Adults 19 to 69, any sex, with Lumbar Disc Herniation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled study comparing non-pharmacological treatment to proactive pharmacological treatment for patient with non-acute lumbar disc herniation with moderate or higher levels of pain. The study involves 200 adult patients aged 19-69, with 50 patients from each participating hospital. Patients will be randomly assigned to either the non-pharmacological treatment group or the pharmacological treatment group 1:1 ratio. Specific interventions will be determined by doctors and Korean medicine doctors without predefined treatment strategies. The non-pharmacological treatment include acupuncture, electroacupuncture, spinal manual therapy and motion style acupuncture. The pharmacological treatment include medication prescription, injection, and nerve block. Treatment period is 8 weeks, and f/u for 3 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lumbar Disc Herniation

Currently open trials in the same condition.

Other Jaseng Medical Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06024460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing